These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 9169305

  • 1. Is there a role for a pure noradrenergic drug in the treatment of depression?
    Montgomery SA.
    Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S3-9; discussion S71-3. PubMed ID: 9169305
    [Abstract] [Full Text] [Related]

  • 2. The role of noradrenaline and selective noradrenaline reuptake inhibition in depression.
    Brunello N, Mendlewicz J, Kasper S, Leonard B, Montgomery S, Nelson J, Paykel E, Versiani M, Racagni G.
    Eur Neuropsychopharmacol; 2002 Oct; 12(5):461-75. PubMed ID: 12208564
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the effectiveness of reboxetine versus fluoxetine in patients with atypical depression: a single-blind, randomized clinical trial.
    Taner E, Demir EY, Cosar B.
    Adv Ther; 2006 Oct; 23(6):974-87. PubMed ID: 17276965
    [Abstract] [Full Text] [Related]

  • 4. Monoamine dysfunction and the pathophysiology and treatment of depression.
    Charney DS.
    J Clin Psychiatry; 1998 Oct; 59 Suppl 14():11-4. PubMed ID: 9818625
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effects of antidepressants on psychomotor function with particular reference to reboxetine.
    Hindmarch I.
    Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S17-21; discussion S71-3. PubMed ID: 9169307
    [Abstract] [Full Text] [Related]

  • 9. Do noradrenaline and serotonin differentially affect social motivation and behaviour?
    Dubini A, Bosc M, Polin V.
    Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S49-55; discussion S71-3. PubMed ID: 9169310
    [Abstract] [Full Text] [Related]

  • 10. [Depressed, lacking motivation, unconcentrated. Signs of central deficiency of noradrenaline].
    MMW Fortschr Med; 2004 Jul 08; 146(27-28):56. PubMed ID: 15526675
    [No Abstract] [Full Text] [Related]

  • 11. Clinical efficacy of reboxetine in major depression.
    Schatzberg AF.
    J Clin Psychiatry; 2000 Jul 08; 61 Suppl 10():31-8. PubMed ID: 10910015
    [Abstract] [Full Text] [Related]

  • 12. Predicting response: noradrenaline reuptake inhibition.
    Montgomery SA.
    Int Clin Psychopharmacol; 1999 May 08; 14 Suppl 1():S21-6. PubMed ID: 10468325
    [Abstract] [Full Text] [Related]

  • 13. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
    Humble M.
    Acta Psychiatr Scand Suppl; 2000 May 08; 402():28-36. PubMed ID: 10901156
    [Abstract] [Full Text] [Related]

  • 14. Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning.
    Dubini A, Bosc M, Polin V.
    J Psychopharmacol; 1997 May 08; 11(4 Suppl):S17-23. PubMed ID: 9438229
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile.
    Hajós M, Fleishaker JC, Filipiak-Reisner JK, Brown MT, Wong EH.
    CNS Drug Rev; 2004 May 08; 10(1):23-44. PubMed ID: 14978512
    [Abstract] [Full Text] [Related]

  • 17. Norepinephrine involvement in antidepressant action.
    Frazer A.
    J Clin Psychiatry; 2000 May 08; 61 Suppl 10():25-30. PubMed ID: 10910014
    [Abstract] [Full Text] [Related]

  • 18. A review of the adverse effects and safety of noradrenergic antidepressants.
    Whiskey E, Taylor D.
    J Psychopharmacol; 2013 Aug 08; 27(8):732-9. PubMed ID: 23784737
    [Abstract] [Full Text] [Related]

  • 19. [SSRI resistant depression. Supplementation with noradrenergic pharmaceuticals can be a good alternative].
    Bodlund O, Häggström L.
    Lakartidningen; 2004 Sep 02; 101(36):2712-4. PubMed ID: 15455633
    [Abstract] [Full Text] [Related]

  • 20. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder.
    Juckel G, Pogarell O, Augustin H, Mulert C, Müller-Siecheneder F, Frodl T, Mavrogiorgou P, Hegerl U.
    J Clin Psychiatry; 2007 Aug 02; 68(8):1206-12. PubMed ID: 17854244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.